Pharmaceutical Compliance Training
Stay Compliant. Stay Informed.

This course provides a clear understanding of the AdvaMed Code of Ethics, the industry standard governing ethical interactions between medical device companies and healthcare professionals (HCPs). Participants will learn key compliance principles for gifts, consulting agreements, and promotional activities in the med-tech sector.

This course deciphers the complex landscape of state-specific licensing, registration, transparency and gift laws affecting life sciences companies. Participants will gain actionable knowledge to comply with diverse licensing requirements, reporting regimes and gift restrictions across key jurisdictions, avoiding costly violations.

This course provides a comprehensive examination of the Federal Anti-Kickback Statute (42 U.S.C. § 1320a-7b), a critical healthcare fraud and abuse law that prohibits improper financial arrangements in federal healthcare programs. Participants will gain practical knowledge of AKS requirements, safe harbors and enforcement trends.

This training covers the principles and practices of maintaining sterility to prevent infections in clinical and surgical settings. Participants will learn hand hygiene, sterile glove techniques, proper gowning, environmental controls, and instrument sterilization. The course is essential for operating room staff, nurses, and other healthcare professionals involved in invasive procedures.

This course educates healthcare workers on OSHA’s Bloodborne Pathogens Standard to minimize exposure risks to infectious diseases such as HIV, hepatitis B, and hepatitis C. Topics include exposure prevention, proper use of personal protective equipment (PPE), safe handling of sharps, post-exposure procedures, and waste disposal protocols. Annual training is required for at-risk personnel.

This course clarifies the vital role of Continuing Medical Education (CME) in advancing clinical practice while defining appropriate pharmaceutical industry involvement. Participants will learn to support accredited CME that prioritizes patient care, maintains independence, and complies with evolving standards.

This course provides a comprehensive understanding of Corporate Integrity Agreements (CIAs)—a critical compliance tool used by the U.S. government to monitor healthcare organizations following fraud settlements. Participants will learn the structure, obligations, and enforcement mechanisms of CIAs, as well as their impact on compliance programs and operations.

This course delivers essential clarity on compliant information dissemination within the pharmaceutical industry. Participants will gain critical insights into current regulatory concerns, learn to implement the latest FDA guidance updates, and master best practices for maintaining full compliance when sharing product information.

This training focuses on preventing electrical hazards in healthcare environments, including equipment malfunctions, shocks, and fires. Participants will learn about safe practices for medical device usage, proper grounding, inspection of electrical cords, and emergency response for electrical incidents.

This course provides a comprehensive understanding of 21 CFR Part 11 requirements for electronic records and signatures in FDA-regulated industries. Participants will learn how to implement compliant systems while meeting validation, security, and documentation standards.

This course provides a comprehensive understanding of the False Claims Act (FCA), a critical U.S. federal law aimed at combating fraud against government programs. Participants will explore the FCA’s legal framework, enforcement mechanisms, whistleblower provisions, and compliance strategies to mitigate risks in government contracting, healthcare, and other regulated industries.

This course provides a clear understanding of the Junk Fax Prevention Act (JFPA) and its amendments to the Telephone Consumer Protection Act (TCPA). Participants will learn the legal requirements for fax marketing, how to obtain proper consent, and strategies to avoid substantial penalties for non-compliance.